InflaRx (IFRX) Tax Rate (2024 - 2025)
InflaRx (IFRX) posted Tax Rate of 0.07% for Q4 2025, down 49.54% sequentially from 0.14% in Q3 2025, and up 4.0% YoY from 0.07% in Q4 2024.
InflaRx (IFRX) Tax Rate (2024 - 2025) Analysis & Trends
InflaRx has reported Tax Rate for 2 years, with the latest figure at 0.07% in Q4 2025.
- Quarterly Tax Rate rose 4.0% year-over-year to 0.07% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.5% (up 30.0% YoY) and the FY2025 annual result came in at 0.03%, down 2.0% from the prior year.
- Tax Rate eased to 0.07% in Q4 2025 per IFRX's latest filing, from 0.14% in the prior quarter.
- Over five years, Tax Rate peaked at 0.14% in Q3 2025 and troughed at 0.02% in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.80 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.53 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 65.33 Bn | 60.14 Bn | 1.37 Bn | 10.91% |
| 4 | Moderna | 59.76 Bn | 54.62 Bn | 52.00 Mn | -1.96% |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | 24.15% |
| 6 | Alnylam Pharmaceuticals | 31.84 Bn | 28.53 Bn | 992.69 Mn | 7.49% |
| 7 | BioNTech SE | 28.23 Bn | 9.84 Bn | 668.28 Mn | 34.12% |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | -16.71% |
| 9 | Royalty Pharma | 27.29 Bn | 26.46 Bn | - | - |
| 10 | InflaRx | 141.98 Mn | -42.27 Mn | 2.74 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.07% |
| Dec 31, 2025 | 0.07% |
| Dec 31, 2025 | 0.07% |
| Sep 30, 2025 | 0.14% |
| Sep 30, 2025 | 0.14% |
| Sep 30, 2025 | 0.14% |
| Dec 31, 2024 | 0.02% |
| Dec 31, 2024 | 0.02% |
| Dec 31, 2024 | 0.02% |
| Sep 30, 2024 | 0.04% |
| Sep 30, 2024 | 0.04% |
| Sep 30, 2024 | 0.04% |